XLO
Xilio Development Inc
NASDAQ: XLO · HEALTHCARE · BIOTECHNOLOGY
$7.92
+1.67% today
Updated 2026-04-30
Market cap
$45.80M
P/E ratio
—
P/S ratio
1.05x
EPS (TTM)
$-4.19
Dividend yield
—
52W range
$6 – $17
Volume
0.2M
Xilio Development Inc (XLO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |